Inito launches portable fertility monitor

Going to the lab for follicular ultrasound scans multiple times every cycle is very strenuous and ovulation kits are unreliable.

The device has been medically tested and the results were found to be comparable to those acquired with clinic-grade instrumentation which cost 100 times more and are 10 times bigger.

A common reason for stress and anxiety for couples trying to have a baby is not knowing their fertile days. There are only a few days every cycle when a woman is fertile and has a high chance of getting pregnant. However, 46 per cent of the cycles vary more than seven days and every one in two couples identify their fertile days wrong thereby delaying conception. Going to the lab for follicular ultrasound scans multiple times every cycle is very strenuous and already available home products like ovulation kits are unreliable and do not work for the hormone levels of Indian women.

Acknowledging this, Inito, a medical technology company has launched a fertility monitor, a home diagnostic test that enables women to track their fertile days at home in an easy and convenient manner. The fertility test is the first test supported by the Inito diagnostic device and has been launched after a successful pilot of six months with 100 users.

Inito is backed by technology that enables smartphones to perform lab-grade medical diagnostic tests at home using a single portable device. Inito diagnostic device comes with the Inito Reader, App and the Test strips. The fertility test works by identifying up to six fertile days of a woman’s cycle. The test strips are dipped in urine and inserted into the device, the device is then attached to the phone and the Inito app displays the result.

Inito Fertility Test not only measures Estrogen and Luteinizing Hormone (LH) in urine but also understands cycle variations and gives highly accurate results unique to every individual woman’s cycle and thus increases the chance of her getting pregnant naturally by 89 per cent.

The device has been medically tested and the results were found to be comparable to those acquired with clinic-grade instrumentation which cost 100 times more and are 10 times bigger.

So far, the company has four patents pending in its name in six geographies including US, European Union, Japan, India, Russia and China and the fertility test is FDA approval exempt even in the US. It has also bagged the three pretigious design awards - CII Design Award, India Design Mark and Japanese Good Design Award.

The company will soon be adding Diabetes, Thyroid and Vitamin D tests to its device. Addition of more tests takes just an App update and ordering the strip for the user. 3rd party strips can also be added to the Inito platform by just an App upgrade. The company raised $1 Million from angel investors in India and Singapore.

The device is priced at Rs 3,195 while a pack of eight fertility test strips costs Rs 895. Right now, users can buy it through Inito’s website or on Amazon. It will soon be available on pharmacies. The company also claims that the system is 99 per cent accurate.